Educating and Supporting Primary Care Providers in the Implementation of Evidence-based Practices for ADHD

NCT02271386 | Completed Results

• 1 other identifier: 14-011189
• Study Type: interventional
• Target: 895
• Locations: 1 country
• Sites: 1

Brief Summary

Although numerous studies have demonstrated that a high percentage of primary care providers (PCPs) are knowledgeable about the American Academy of Pediatrics' guidelines for managing ADHD, many fail to implement these guidelines correctly. The goal of this project is to increase the use of evidence-based practices (EBP) for assessing and treating children with ADHD between 5 and 12 years in the context of primary care practice. This randomized controlled trial will evaluate the whether a 3-part intervention (education about ADHD management and communication training, collaborative consultation, and performance feedback regarding use of EBPs) is effective in improving EBP use among primary care providers.

Conditions

Attention Deficit Hyperactivity Disorder

Keywords

Evidence-Based Practice; Provider Education

Outcome Measures

Primary Outcomes (8)

• Number of Patients Who Were Sent the Parents Rating Scale

  This measure is based on chart review of patients of clinicians in each study arm (up to 4 patients per clinician) and reflects whether there is evidence that a parent rating scale was sent out during the baseline interval

  Baseline Period (8 months)

• Number of Patients Whose Parent Rating Scale Was Returned

  This measure is based on chart review of patients of clinicians in each study arm (up to 4 patients per clinician) and reflects whether there is evidence that a parent rating scale was received by the clinician during the baseline interval

  Baseline Period (8 months)

• Number of Patients Who Were Sent the Teacher Rating Scale

  This measure is based on chart review of patients of clinicians in each study arm (up to 4 patients per clinician) and reflects whether there is evidence that a teacher rating scale was sent out during the baseline interval

  Baseline Period (8 months)

• Number of Patients Whose Teacher Rating Scale Was Returned

  This measure is based on chart review of patients of clinicians in each study arm (up to 4 patients per clinician) and reflects whether there is evidence that a teacher rating scale was received by the clinician during the baseline interval

  Baseline Period (8 months)

• Number of Patients Who Were Sent the Parents Rating Scale

  This measure is based on chart review of patients of clinicians in each study arm (up to 4 patients per clinician) and reflects whether there is evidence that a parent rating scale was sent out during the intervention interval

  Intervention Period (8 months)

• Number of Patients Whose Parent Rating Scale Was Returned

  This measure is based on chart review of patients of clinicians in each study arm (up to 4 patients per clinician) and reflects whether there is evidence that a parent rating scale was received by the clinician during the intervention interval

  Intervention Period (8 months)

• Number of Patients Who Were Sent the Teacher Rating Scale

  This measure is based on chart review of patients of clinicians in each study arm (up to 4 patients per clinician) and reflects whether there is evidence that a teacher rating scale was sent out during the intervention interval

  Intervention Period (8 months)

• Number of Patients Whose Teacher Rating Scale Was Returned

  This measure is based on chart review of patients of clinicians in each study arm (up to 4 patients per clinician) and reflects whether there is evidence that a teacher rating scale was received by the clinician during the intervention interval

  Intervention Period (8 months)

Secondary Outcomes (20)

• Number of Patients Who Were Sent the Parent Rating Scale - by MOC Status

  Baseline Period (8 months)

• Number of Patients Whose Parent Rating Scale Was Returned- by MOC Status

  Baseline Period (8 months)

• Number of Patients Who Were Sent the Teacher Rating Scale- by MOC Status

  Baseline Period (8 months)

• Number of Patients Whose Teacher Rating Scale Was Returned- by MOC Status

  Baseline Period (8 months)

• Number of Patients Who Were Sent the Parent Rating Scale- by MOC Status

  Intervention Period (8 months)

Study Arms (2)

Intervention

EXPERIMENTAL

Clinicians in the intervention arm will receive the three-part intervention (Supporting Practice for ADHD, or SPA) which includes: education about ADHD management and communication training, collaborative consultation, and performance feedback, for the first 8 months of the study.

Behavioral: Supporting Practice for ADHD (SPA)

Control

OTHER

Clinicians in the control arm will receive no intervention for the first 8 months of the study, then will receive the full SPA intervention for the last 8 months of the study.

Behavioral: Supporting Practice for ADHD (SPA)

Interventions

Supporting Practice for ADHD (SPA) BEHAVIORAL

The SPA intervention will last for 8 months for each study arm (first 8 months of the study for the intervention group, last 8 months for the control group). The intervention includes 3 components: 1) a series of web-based educational presentations to provide education to providers about evidence-based practice for managing ADHD and strategies for promoting effective communication with families 2) Collaborative consultation designed to address clinical issues arising in practice will be provided by members of the study team. 3\) Providers will be given systematic performance feedback with regard to their use of evidence-based practices for ADHD every 2 months during the 8-month intervention period.

Control; Intervention

Eligibility Criteria

• Age: 5 Years - 12 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17)

You may qualify if:

• Non-resident clinician (physician or nurse practitioner) at participating site

You may not qualify if:

• Residents
• Secondary Subjects: Families
• Children aged 5-12 years receiving care from a clinician enrolled in the study for ADHD and their parents
• Autism spectrum disorder

Sponsors & Collaborators

• Children's Hospital of Philadelphia: lead

Study Sites (1)

Children's Hospital of Philadelphia

Philadelphia, Pennsylvania, 19103, United States

Location

MeSH Terms

Conditions

Attention Deficit Disorder with Hyperactivity

Condition Hierarchy (Ancestors)

Attention Deficit and Disruptive Behavior Disorders; Neurodevelopmental Disorders; Mental Disorders

Limitations and Caveats

Enrollment occurred within 1 health system among clinicians who were interested in participating in the project and worked in practices that agreed to participate, which may limit generalizability of results.

Results Point of Contact

• Title: Alexander Fiks, MD, MSCE
• Organization: The Children's Hospital of Philadelphia

fiks@email.chop.edu

2674262304

Study Officials

• Alexander G Fiks, MD, MSCE

  Children's Hospital of Philadelphia

  PRINCIPAL INVESTIGATOR

• Thomas Power, PhD

  Children's Hospital of Philadelphia

  PRINCIPAL INVESTIGATOR

Publication Agreements

• PI is Sponsor Employee: Yes
• Restrictive Agreement: No

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: TREATMENT
• Intervention Model: CROSSOVER
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: October 13, 2014
• First Posted: October 22, 2014
• Study Start: November 1, 2014
• Primary Completion: July 31, 2016
• Study Completion: July 31, 2016
• Last Updated: March 18, 2019
• Results First Posted: March 18, 2019

Record last verified: 2019-03

Locations

US (1)